Stocks Close Out A Big First Quarter… And The True Cost Of Diabetes Drugs 3/28/24
CNBC's "Fast Money"
00:00
Uncovering the Disparity
This chapter critiques the exorbitant pricing of a popular diabetes drug compared to its manufacturing cost, determined through detailed research and interviews with manufacturers. It also explores the implications of high drug costs for patients, discussing the need for fair pricing strategies and alternative payment models.
Play episode from 32:51
Transcript
